Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

47.1%

8 terminated/withdrawn out of 17 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

150%

12 of 8 completed trials have results

Key Signals

12 with results7 terminated

Enrollment Performance

Analytics

N/A
12(85.7%)
Phase 1
2(14.3%)
14Total
N/A(12)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (17)

Showing 17 of 17 trials
NCT04797390Not ApplicableCompleted

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Role: lead

NCT07165340Phase 1Enrolling By Invitation

Evaluation of Lymphatic Response to Physiotherapy in Patients With Swelling Associated With Superficial Venous Disease

Role: collaborator

NCT04432727Not ApplicableCompleted

Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.

Role: lead

NCT02661646Terminated

Quality of Life Changes on Lower Extremity Lymphedema Patients Using an Advanced Pneumatic Compression Device (PCD)

Role: lead

NCT04073823Not ApplicableTerminated

A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients

Role: lead

NCT04335981Not ApplicableTerminated

Determining Swallow Outcomes in Head & Neck Lymphedema Subjects Receiving Early Intervention With Pneumatic Compression

Role: lead

NCT04213989Not ApplicableCompleted

Intermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema With Swelling)

Role: collaborator

NCT04116099Terminated

CVR Registry Evaluating Flexitouch Plus and Conservative Care vs Conservative Care Only for Treatment of Lymphedema

Role: lead

NCT02031627Not ApplicableCompleted

Treatment Response to Different Lymphoedema Compression Programs Using a Pneumatic Compression Device

Role: lead

NCT01239160Not ApplicableTerminated

Two Pneumatic Compression Devices in the Treatment of Lower Extremity Lymphedema

Role: lead

NCT03558672Terminated

A Registry to Evaluate the Flexitouch System and Flexitouch Plus for Treatment of Head and Neck Lymphedema

Role: lead

NCT04276454Not ApplicableWithdrawn

Lymphedema Treatment in Head and Neck Cancer Patients

Role: collaborator

NCT03332160Not ApplicableCompleted

A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck Treatment

Role: lead

NCT02680834Not ApplicableTerminated

VLU Non-Inferiority Study Comparing a Dual Action Pneumatic Compression Device to Multi-Layer Bandaging

Role: lead

NCT02946021Phase 1Completed

Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema

Role: lead

NCT02395302Not ApplicableCompleted

Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers (VLUs)

Role: lead

NCT02015221Not ApplicableCompleted

Evaluation of a Dual Action Pneumatic Compression Device: Patient Ease of Use and Comfort

Role: lead

All 17 trials loaded